Dysregulation of microRNA biogenesis and gene silencing in cancer

Science Signaling

Volumn 8, Issue 368, 2015, Pages re3-

  Hata, Akiko ^a   Lieberman, Judy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 1 PROTEIN; ARGONAUTE 2 PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CASPASE 8; EPIDERMAL GROWTH FACTOR RECEPTOR; HISTONE DEACETYLASE 1; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 17 92; MICRORNA 195; MICRORNA 200; MICRORNA 210; MICRORNA 221; MICRORNA 34A; PROTEIN P53; RECEPTOR REGULATED SMAD PROTEIN; RNA POLYMERASE II; SIRTUIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; RNA;

APOPTOSIS; BIOGENESIS; BIOSYNTHESIS; CANCER PROGNOSIS; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; CYTOKINE PRODUCTION; DNA BINDING; DNA DAMAGE; DNA REPAIR; ENDOPLASMIC RETICULUM STRESS; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGUS CANCER; GENE EXPRESSION; GENE SILENCING; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; HYPOXIA; INFLAMMATION; INTRACELLULAR SIGNALING; LOSS OF FUNCTION MUTATION; LUNG ADENOCARCINOMA; METASTASIS; MICROPROCESSOR; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SOMATIC MUTATION; SUMOYLATION; TREATMENT RESPONSE; UBIQUITINATION; ANIMAL; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; RNA, NEOPLASM;

EID: 84924962270     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005825     Document Type: Review

References (140)

1. V. N. Kim, J. Han, M. C. Siomi, Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139 (2009).
2. H. Siomi, M. C. Siomi, Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 38, 323-332 (2010).
3. J. S. Yang, E. C. Lai, Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol. Cell 43, 892-903 (2011).
4. G. Meister, Argonaute proteins: Functional insights and emerging roles. Nat. Rev. Genet. 14, 447-459 (2013).
5. D. P. Bartel, MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009).
6. J. T. Mendell, E. N. Olson, MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187 (2012).
7. G. Di Leva, M. Garofalo, C. M. Croce, MicroRNAs in cancer. Annu. Rev. Pathol. 9, 287-314 (2014).
8. A. Ventura, T. Jacks, MicroRNAs and cancer: Short RNAs go a long way. Cell 136, 586-591 (2009).
9. K. A. O'Donnell, E. A. Wentzel, K. I. Zeller, C. V. Dang, J. T. Mendell, c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839-843 (2005).
10. L. He, X. He, L. P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A. L. Jackson, P. S. Linsley, C. Chen, S. W. Lowe, M. A. Cleary, G. J. Hannon, A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (2007).
11. R. Kulshreshtha, M. Ferracin, S. E. Wojcik, R. Garzon, H. Alder, F. J. Agosto-Perez, R. Davuluri, C. G. Liu, C. M. Croce, M. Negrini, G. A. Calin, M. Ivan, A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867 (2007).
12. J. Pothof, N. S. Verkaik, W. van IJcken, E. A. Wiemer, V. T. Ta, G. T. van der Horst, N. G. Jaspers, D. C. van Gent, J. H. Hoeijmakers, S. P. Persengiev, MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J. 28, 2090-2099 (2009).
13. J. H. Yoon, K. Abdelmohsen, S. Srikantan, X. Yang, J. L. Martindale, S. De, M. Huarte, M. Zhan, K. G. Becker, M. Gorospe, LincRNA-p21 suppresses target mRNA translation. Mol. Cell 47, 648-655 (2012).
14. E. Sotillo, T. Laver, H. Mellert, J. M. Schelter, M. A. Cleary, S. McMahon, A. Thomas-Tikhonenko, Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 30, 2587-2594 (2011).
15. M. Dews, A. Homayouni, D. Yu, D. Murphy, C. Sevignani, E. Wentzel, E. E. Furth, W. M. Lee, G. H. Enders, J. T. Mendell, A. Thomas-Tikhonenko, Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38, 1060-1065 (2006).
16. O. Voinnet, Origin, biogenesis, and activity of plant microRNAs. Cell 136, 669-687 (2009).
17. M. Ha, V. N. Kim, Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15, 509-524 (2014).
18. R. C. Lee, R. L. Feinbaum, V. Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (1993).
19. B. J. Reinhart, F. J. Slack, M. Basson, A. E. Pasquinelli, J. C. Bettinger, A. E. Rougvie, H. R. Horvitz, G. Ruvkun, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906 (2000).
20. J. Brennecke, D. R. Hipfner, A. Stark, R. B. Russell, S. M. Cohen, bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36 (2003).
21. P. Xu, S. Y. Vernooy, M. Guo, B. A. Hay, The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 13, 790-795 (2003).
22. G. A. Calin, C. D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich, C. M. Croce, Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99, 15524-15529 (2002).
23. J. Lu, G. Getz, E. A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B. L. Ebert, R. H. Mak, A. A. Ferrando, J. R. Downing, T. Jacks, H. R. Horvitz, T. R. Golub, MicroRNA expression profiles classify human cancers. Nature 435, 834-838 (2005).
24. D. Lutter, C. Marr, J. Krumsiek, E. W. Lang, F. J. Theis, Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects. BMC Genomics 11, 224 (2010).
25. O. A. Kent, J. T. Mendell, A small piece in the cancer puzzle: MicroRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188-6196 (2006).
26. T. C. Chang, D. Yu, Y. S. Lee, E. A. Wentzel, D. E. Arking, K. M. West, C. V. Dang, A. Thomas-Tikhonenko, J. T. Mendell, Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 40, 43-50 (2008).
27. T. C. Chang, E. A. Wentzel, O. A. Kent, K. Ramachandran, M. Mullendore, K. H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C. J. Lowenstein, D. E. Arking, M. A. Beer, A. Maitra, J. T. Mendell, Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752 (2007).
28. F. Navarro, D. Gutman, E. Meire, M. Cáceres, I. Rigoutsos, Z. Bentwich, J. Lieberman, miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 114, 2181-2192 (2009).
29. A. Lal, M. P. Thomas, G. Altschuler, F. Navarro, E. O'Day, X. L. Li, C. Concepcion, Y. C. Han, J. Thiery, D. K. Rajani, A. Deutsch, O. Hofmann, A. Ventura, W. Hide, J. Lieberman, Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLOS Genet. 7, e1002363 (2011).
30. D. C. Corney, C. I. Hwang, A. Matoso, M. Vogt, A. Flesken-Nikitin, A. K. Godwin, A. A. Kamat, A. K. Sood, L. H. Ellenson, H. Hermeking, A. Y. Nikitin, Frequent downregulation of miR-34 family in human ovarian cancers. Clin. Cancer Res. 16, 1119-1128 (2010).
31. A. L. Kasinski, F. J. Slack, miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res. 72, 5576-5587 (2012).
32. N. Okada, C. P. Lin, M. C. Ribeiro, A. Biton, G. Lai, X. He, P. Bu, H. Vogel, D. M. Jablons, A. C. Keller, J. E. Wilkinson, B. He, T. P. Speed, L. He, A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 28, 438-450 (2014).
33. S. Hahn, R. Jackstadt, H. Siemens, S. Hünten, H. Hermeking, SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J. 32, 3079-3095 (2013).
34. H. Siemens, R. Jackstadt, S. Hünten, M. Kaller, A. Menssen, U. Götz, H. Hermeking, miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10, 4256-4271 (2011).
35. R. Song, P. Walentek, N. Sponer, A. Klimke, J. S. Lee, G. Dixon, R. Harland, Y. Wan, P. Lishko, M. Lize, M. Kessel, L. He, miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature 510, 115-120 (2014).
36. C. P. Concepcion, Y. C. Han, P. Mu, C. Bonetti, E. Yao, A. D'Andrea, J. A. Vidigal, W. P. Maughan, P. Ogrodowski, A. Ventura, Intact p53-dependent responses in miR-34-deficient mice. PLOS Genet. 8, e1002797 (2012).
37. C. L. Daige, J. F. Wiggins, L. Priddy, T. Nelligan-Davis, J. Zhao, D. Brown, Systemic delivery of a miR-34a mimic as a potential therapeutic for liver cancer. Mol. Cancer Ther. 13, 2352-2360 (2014).
38. H. Hu, R. A. Gatti, MicroRNAs: New players in the DNA damage response. J. Mol. Cell Biol. 3, 151-158 (2011).
39. A. Lal, Y. Pan, F. Navarro, D. M. Dykxhoorn, L. Moreau, E. Meire, Z. Bentwich, J. Lieberman, D. Chowdhury, miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat. Struct. Mol. Biol. 16, 492-498 (2009).
40. G. Wan, X. Zhang, R. R. Langley, Y. Liu, X. Hu, C. Han, G. Peng, L. M. Ellis, S. N. Jones, X. Lu, DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway. Cell Rep. 3, 2100-2112 (2013).
41. Y. E. Choi, Y. Pan, E. Park, P. Konstantinopoulos, S. De, A. D'Andrea, D. Chowdhury, MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability. eLife 3, e02445 (2014).
42. W. Hu, C. S. Chan, R. Wu, C. Zhang, Y. Sun, J. S. Song, L. H. Tang, A. J. Levine, Z. Feng, Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol. Cell 38, 689-699 (2010).
43. M. T. Le, C. Teh, N. Shyh-Chang, H. Xie, B. Zhou, V. Korzh, H. F. Lodish, B. Lim, MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862-876 (2009).
44. T. van den Beucken, E. Koch, K. Chu, R. Rupaimoole, P. Prickaerts, M. Adriaens, J. W. Voncken, A. L. Harris, F. M. Buffa, S. Haider, M. H. Starmans, C. Q. Yao, M. Ivan, C. Ivan, C. V. Pecot, P. C. Boutros, A. K. Sood, M. Koritzinsky, B. G. Wouters, Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat. Commun. 5, 5203 (2014).
45. R. Rupaimoole, S. Y. Wu, S. Pradeep, C. Ivan, C. V. Pecot, K. M. Gharpure, A. S. Nagaraja, G. N. Armaiz-Pena, M. McGuire, B. Zand, H. J. Dalton, J. Filant, J. B. Miller, C. Lu, N. C. Sadaoui, L. S. Mangala, M. Taylor, T. van den Beucken, E. Koch, C. Rodriguez-Aguayo, L. Huang, M. Bar-Eli, B. G. Wouters, M. Radovich, M. Ivan, G. A. Calin, W. Zhang, G. Lopez-Berestein, A. K. Sood, Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression. Nat. Commun. 5, 5202 (2014).
46. M. Ivan, X. Huang, miR-210: Fine-tuning the hypoxic response. Adv. Exp. Med. Biol. 772, 205-227 (2014).
47. C. Devlin, S. Greco, F. Martelli, M. Ivan, miR-210: More than a silent player in hypoxia. IUBMB life 63, 94-100 (2011).
48. E. Tili, J. J. Michaille, C. M. Croce, MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol. Rev. 253, 167-184 (2013).
49. F. Yu, H. Yao, P. Zhu, X. Zhang, Q. Pan, C. Gong, Y. Huang, X. Hu, F. Su, J. Lieberman, E. Song, let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
50. E. Piskounova, C. Polytarchou, J. E. Thornton, R. J. LaPierre, C. Pothoulakis, J. P. Hagan, D Iliopoulos, R. I. Gregory, Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell 147, 1066-1079 (2011).
51. I. Heo, C. Joo, Y. K. Kim, M. Ha, M. J. Yoon, J. Cho, K. H. Yeom, J. Han, V. N. Kim, TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138, 696-708 (2009).
52. J. P. Hagan, E. Piskounova, R. I. Gregory, Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 16, 1021-1025 (2009).
53. J. E. Thornton, R. I. Gregory, How does Lin28 let-7 control development and disease? Trends Cell Biol. 22, 474-482 (2012).
54. S. R. Viswanathan, G. Q. Daley, R. I. Gregory, Selective blockade of microRNA processing by Lin28. Science 320, 97-100 (2008).
55. M. A. Newman, J. M. Thomson, S. M. Hammond, Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14, 1539-1549 (2008).
56. H. M. Chang, R. Triboulet, J. E. Thornton, R. I. Gregory, A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway. Nature 497, 244-248 (2013).
57. D. Ustianenko, D. Hrossova, D. Potesil, K. Chalupnikova, K. Hrazdilova, J. Pachernik, K. Cetkovska, S. Uldrijan, Z. Zdrahal, S. Vanacova, Mammalian DIS3L2 exoribonu-clease targets the uridylated precursors of let-7 miRNAs. RNA 19, 1632-1638 (2013).
58. P. Smibert, J. S. Yang, G. Azzam, J. L Liu, E. C. Lai, Homeostatic control of Argonaute stability by microRNA availability. Nat. Struct. Mol. Biol. 20, 789-795 (2013).
59. D. Astuti, M. R. Morris, W. N. Cooper, R. H. Staals, N. C. Wake, G. A. Fews, H. Gill, D. Gentle, S. Shuib, C. J. Ricketts, T. Cole, A. J. van Essen, R. A. van Lingen, G. Neri, J. M. Opitz, P. Rump, I. Stolte-Dijkstra, F. Müller, G. J. Pruijn, F. Latif, E. R. Maher, Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility. Nat. Genet. 44, 277-284 (2012).
60. T. C. Chang, L R. Zeitels, H. W. Hwang, R. R. Chivukula, E. A. Wentzel, M. Dews, J. Jung, P. Gao, C. V. Dang, M. A. Beer, A. Thomas-Tikhonenko, J. T. Mendell, Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. U.S.A. 106, 3384-3389 (2009).
61. S. R.Viswanathan, J. T. Powers, W. Einhorn, Y. Hoshida, T. L. Ng, S. Toffanin, M. O'Sullivan, J. Lu, L A. Phillips, V. L Lockhart, S. P. Shah, P. S. Tanwar, C. H. Mermel, R. Beroukhim, M. Azam, J. Teixeira, M. Meyerson, T. P. Hughes, J. M. Llovet, J. Radich, C. G. Mullighan, T. R. Golub, P. H. Sorensen, G. Q. Daley, Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 41, 843-848 (2009).
62. J. Takamizawa, H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi, T. Takahashi, Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756 (2004).
63. S. M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K. L. Reinert, D. Brown, F. J. Slack, RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (2005).
64. C. Mayr, M. T. Hemann, D. P. Bartel, Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579 (2007).
65. L. J. Chin, E. Ratner, S. Leng, R. Zhai, S. Nallur, I. Babar, R. U. Muller, E. Straka, L. Su, E. A. Burki, R. E. Crowell, R. Patel, T. Kulkarni, R. Homer, D. Zelterman, K. K. Kidd, Y. Zhu, D. C. Christiani, S. A. Belinsky, F. J. Slack, J. B. Weidhaas, A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res. 68, 8535-8540 (2008).
66. M. S. Kumar, E. Armenteros-Monterroso, P. East, P. Chakravorty, N. Matthews, M. M. Winslow, J. Downward, HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature505, 212-217 (2014).
67. V. Olive, Q. Li, L. He, mir-17-92: A polycistronic oncomir with pleiotropic functions. Immunol. Rev. 253, 158-166 (2013).
68. L. He, J. M. Thomson, M. T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S. W. Lowe, G. J. Hannon, S. M. Hammond, A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005).
69. Y. Li, L. M. Vecchiarelli-Federico, Y. J. Li, S. E. Egan, D. Spaner, M. R. Hough, Y. Ben-David, The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood 119, 4486-4498 (2012).
70. D. Nittner, I. Lambertz, F.Clermont, P. Mestdagh, C. Köhler, S.J. Nielsen, A. Jochemsen, F. Speleman, J. Vandesompele, M. A. Dyer, A. Schramm, J. H. Schulte, J. C. Marine, Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors sup presses retinoblastoma formation. Nat. Cell Biol. 14, 958-965 (2012).
71. V. Olive, E. Sabio, M.J. Bennett, CS. De Jong, A. Biton, J.C. McGann, S. K. Greaney, N. M. Sodir, A. Y. Zhou, A. Balakrishnan, M. Foth, M. A. Luftig, A. Goga, T. P. Speed, Z. Xuan, G. I. Evan, Y. Wan, A. C. Minella, L. He, A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. eLife2, e00822 (2013).
72. C. Xiao, L Srinivasan, D. P. Calado, H. C. Patterson, B. Zhang, J. Wang, J. M. Henderson, J. L. Kutok, K. Rajewsky, Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405-414 (2008).
73. A. Ventura, A. G. Young, M. M. Winslow, L Lintault, A. Meissner, S. J. Erkeland, J. Newman, R. T. Bronson, D. Crowley, J. R. Stone, R. Jaenisch, P. A. Sharp, T. Jacks, Targeted deletion reveals essential and overlapping functions of the miR-17~92 family of miRNA clusters. Cell 132, 875-886 (2008).
74. P. S. Mongroo, A. K. Rustgi, The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol. Ther. 10, 219-222 (2010).
75. D. M. Dykxhoorn, Y. Wu, H. Xie, F. Yu, A. Lal, F. Petrocca, D. Martinvalet, E. Song, B. Lim, J. Lieberman, miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLOS One 4, e7181 (2009).
76. M. Korpal, E. S. Lee, G. Hu, Y. Kang, The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914 (2008).
77. M. T. Le, P. Hamar, C. Guo, E. Basar, R. Perdigão-Henriques, L. Balaj, J. Lieberman, miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J. Clin. Invest. 124, 5109-5128 (2014).
78. R. Perdigão-Henriques, F. Petrocca, G. Altschuler, M. P. Thomas, M. T. N. Le, S. M. Tan, W. Hide, J. Lieberman, miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Oncogene in press (2015).
79. C. P. Bracken, X. Li, J. A. Wright, D. M. Lawrence, K. A. Pillman, M. Salmanidis, M. A. Anderson, B. K. Dredge, P. A. Gregory, A. Tsykin, C. Neilsen, D. W. Thomson, A. G. Bert, J. M. Leerberg, A. S. Yap, K. B. Jensen, Y. Khew-Goodall, G. J. Goodall, Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBOJ. 33, 2040-2056 (2014).
80. D. Iliopoulos, C. Polytarchou, M. Hatziapostolou, F. Kottakis, I. G. Maroulakou, K. Struhl, P. N. Tsichlis, MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci. Signal. 2, ra62 (2009).
81. T. Xu, Y. Zhu, Y. Xiong, Y. Y. Ge, J. P. Yun, S. M. Zhuang, MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50, 113-121 (2009).
82. J. Liz, A. Portela, M. Soler, A. Gómez, H. Ling, G. Michlewski, G. A. Calin, S. Guil, M. Esteller, Regulation of pri-miRNA processing by a long noncoding RNA transcribed from an ultraconserved region. Mol. Cell55, 138-147 (2014).
83. A. Lujambio, A. Portela, J. Liz, S. A. Melo, S. Rossi, R. Spizzo, C. M. Croce, G. A. Calin, M. Esteller, CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene 29, 6390-6401 (2010).
84. H. I. Suzuki, M. Arase, H. Matsuyama, Y. L Choi, T. Ueno, H. Mano, K. Sugimoto, K. Miyazono, MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 44, 424-436 (2011).
85. J. P. Upton, L Wang, D. Han, E. S. Wang, N. E. Huskey, L Lim, M. Truitt, M. T. McManus, D. Ruggero, A. Goga, F. R. Papa, S. A. Oakes, IRE1a cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2. Science 338, 818-822 (2012).
86. V. Libri, A. Helwak, P. Miesen, D. Santhakumar, J. G. Borger, G. Kudla, F. Grey, D. Tollervey, A. H. Buck, Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target. Proc. Natl. Acad. Sci. U.S.A. 109, 279-284 (2012).
87. S. Rüegger, H. Grobhans, MicroRNA turnover: When, how, and why. Trends Biochem. Sci. 37, 436-446 (2012).
88. S. K. Das, U. K. Sokhi, S. K. Bhutia, B. Azab, Z. Z. Su, D. Sarkar, P. B. Fisher, Human polynucleotide phosphorylase selectively and preferentially degrades micro-RNA-221 in human melanoma cells. Proc. Natl. Acad. Sci. USA. 107, 11948-11953 (2010).
89. M. S. Kumar, J. Lu, K. L. Mercer, T. R. Golub, T. Jacks, Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 39, 673-677 (2007).
90. M. S. Kumar, R. E. Pester, C. Y. Chen, K. Lane, C. Chin, J. Lu, D. G. Kirsch, T. R. Golub, T. Jacks, Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev. 23, 2700-2704 (2009).
91. I. Lambertz, D. Nittner, P. Mestdagh, G. Denecker, J. Vandesompele, M. A. Dyer, J. C. Marine, Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo. Cell Death Differ. 17, 633-641 (2010).
92. G. Martello, A. Rosato, F. Ferrari, A. Manfrin, M. Cordenonsi, S. Dupont, E. Enzo, V. Guzzardo, M. Rondina, T. Spruce, A. R. Parenti, M. G. Daidone, S. Bicciato, S. Piccolo, A microRNA targeting dicer for metastasis control. Cell 141, 1195-1207 (2010).
93. M. Yan, H. Y. Huang, T. Wang, Y. Wan, S. D. Cui, Z. Z. Liu, Q. X. Fan, Dysregulated expression of Dicer and Drosha in breast cancer. Pathol. Oncol. Res. 18, 343-348 (2012).
94. A. Torres, K. Torres, T. Paszkowski, B. Jodtowska-Jçdrych, T. Radomaiîski, A. Ksia^zek, R. Maciejewski, Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. Tumour Biol. 32, 769-776 (2011).
95. R. J. Lin, Y. C. Lin, J. Chen, H. H. Kuo, Y. Y. Chen, M. B. Diccianni, W. B. London, C. H. Chang, A. L. Yu, microRNA signature and expression of Dicerand Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res. 70, 7841-7850 (2010).
96. W. M. Merritt, Y. G. Lin, L. Y. Han, A. A. Kamat, W. A. Spannuth, R. Schmandt, D. Urbauer, L A. Pennacchio, J. F. Cheng, A. M. Nick, M. T. Deavers, A. Mourad-Zeidan, H. Wang, P. Mueller, M. E. Lenburg, J. W. Gray, S. Mok, M. J. Birrer, G. Lopez-Berestein, R. L Coleman, M. Bar-Eli, A. K. Sood, Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl. J. Med. 359, 2641-2650 (2008).
97. B. Kim, J. H. Lee, J. W. Park, T. K. Kwon, S. K. Baek, I. Hwang, S. Kim, An essential microRNA maturing microprocessor complex component DGCR8 is up-regulated in colorectal carcinomas. Clin. Exp. Med. 14, 331-336 (2014).
98. J. W. Catto, S. Miah, H. C. Owen, H. Bryant, K. Myers, E. Dudziec, S. Larré, M. Milo, I. Rehman, D. J. Rosario, E. Di Martino, M. A. Knowles, M. Meuth, A. L. Harris, F. C. Hamdy, Distinct microRNA alterations characterize high-and low-grade bladder cancer. Cancer Res. 69, 8472-8481 (2009).
99. S. Chiosea, E. Jelezcova, U. Chandran, M. Acquafondata, T. McHale, R. W. Sobol, R. Dhir, Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 169, 1812-1820 (2006).
100. S. Chiosea, E. Jelezcova, U. Chandran, J. Luo, G. Mantha, R. W. Sobol, S. Dacic, Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67, 2345-2350 (2007).
101. W. D. Foulkes, J. R. Priest, T. F. Duchaine, DICER1: Mutations, microRNAs and mechanisms. Nat. Rev. Cancer 14, 662-672 (2014).
102. G. T. Torrezan, E. N. Ferreira, A. M. Nakahata, B. D. Barros, M. T. Castro, B. R. Correa, A. C. Krepischi, E. H. Olivieri, I. W. Cunha, U. Tabori, P. E. Grundy, C. M. Costa, B. de Camargo, P. A. Galante, D. M. Carraro, Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour. Nat. Commun. 5, 4039 (2014).
103. D. Rakheja, K. S. Chen, Y. Liu, A. A. Shukla, V. Schmid, T. C. Chang, S. Khokhar, J. E. Wickiser, N. J. Karandikar, J. S. Malter, J. T. Mendell, J. F. Amatruda, Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours. Nat. Commun. 2, 4802 (2014).
104. D. A. Hill, J. Ivanovich, J.R. Priest, C. A. Gurnett, L. P. Dehner, D. Desruisseau, J. A. Jarzembowski, K. A. Wikenheiser-Brokamp, B. K. Suarez, A. J. Whelan, G. Williams, D. Bracamontes, Y. Messinger, P. J. Goodfellow, DICER1 mutations in familial pleuro-pulmonary blastoma. Science 325, 965 (2009).
105. L. Doros, J. Yang, L. Dehner, C. T. Rossi, K. Skiver, J. A. Jarzembowski, Y. Messinger, K. A. Schultz, G. Williams, N. André, D. A. Hill, DICER1 mutations in embryonal rhab-domyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr. Blood Cancer 59, 558-560 (2012).
106. E. Tomiak, L. de Kock, D. Grynspan, R. Ramphal, W. D. Foulkes, DICER1 mutations in an adolescent with cervical embryonal rhabdomyosarcoma (cERMS). Pediatr. Blood Cancer 61, 568-569 (2014).
107. S. A. Melo, C. Moutinho, S. Ropero, G. A. Calin, S. Rossi, R. Spizzo, A. F. Fernandez, V. Davalos, A. Villanueva, G. Montoya, H. Yamamoto, S. Schwartz Jr., M. Esteller, A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18, 303-315 (2010).
108. S. A. Melo, S. Ropero, C. Moutinho, L. A. Aaltonen, H. Yamamoto, G. A. Calin, S. Rossi, A. F. Fernandez, F. Carneiro, C. Oliveira, B. Ferreira, C. G. Liu, A. Villanueva, G. Capella, S. Schwartz Jr., R. Shiekhattar, M. Esteller, A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41, 365-370 (2009).
109. J. Massagué, TGFb signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630 (2012).
110. B. N. Davis, A. C. Hilyard, G. Lagna, A. Hata, SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61 (2008).
111. M. E. Hatley, D. M. Patrick, M. R. Garcia, J. A. Richardson, R. Bassel-Duby, E. van Rooij, E. N. Olson, Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18, 282-293 (2010).
112. B. N. Davis, A. C. Hilyard, P. H. Nguyen, G. Lagna, A. Hata, Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 39, 373-384 (2010).
113. H. I. Suzuki, K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, K. Miyazono, Modulation of microRNA processing by p53. Nature 460, 529-533 (2009).
114. J. Chang, B. N. Davis-Dusenbery, R. Kashima, X. Jiang, N. Marathe, R. Sessa, J. Louie, W. Gu, G. Lagna, A. Hata, Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress. EMBO J. 32, 3192-3205 (2013).
115. M. Trabucchi, P. Briata, M. Garcia-Mayoral, A. D. Haase, W. Filipowicz, A. Ramos, R. Gherzi, M. G. Rosenfeld, The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459, 1010-1014 (2009).
116. P. Briata, W. J. Lin, M. Giovarelli, M. Pasero, C. F. Chou, M. Trabucchi, M. G. Rosenfeld, C. Y. Chen, R. Gherzi, PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ. 19, 478-487 (2012).
117. X. Zhang, G. Wan, F. G. Berger, X. He, X. Lu, The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41, 371-383 (2011).
118. J. P. Radich, H. Dai, M. Mao, V. Oehler, J. Schelter, B. Druker, C. Sawyers, N. Shah, W. Stock, C. L. Willman, S. Friend, P. S. Linsley, Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 103, 2794-2799 (2006).
119. M. Mori, R. Triboulet, M. Mohseni, K. Schlegelmilch, K. Shrestha, F. D. Camargo, R. I. Gregory, Hippo signaling regulates Microprocessor and links cell density-dependent miRNA biogenesis to cancer. Cell 156, 893-906 (2014).
120. W. Yang, T. P. Chendrimada, Q. Wang, M. Higuchi, P. H. Seeburg, R. Shiekhattar, K. Nishikura, Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13, 13-21 (2006).
121. Y. Nemlich, E. Greenberg, R. Ortenberg, M. J. Besser, I. Barshack, J. Jacob-Hirsch, E. Jacoby, E. Eyal, L. Rivkin, V. G. Prieto, N. Chakravarti, L. M. Duncan, D. M. Kallenberg, E. Galun, D. C. Bennett, N. Amariglio, M. Bar-Eli, J. Schachter, G. Rechavi, G. Markel, MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J. Clin. Invest. 123, 2703-2718 (2013).
122. H.Ota, M. Sakurai, R. Gupta, L. Valente, B. E.Wulff, K. Ariyoshi, H. Iizasa, R. V. Davuluri, K. Nishikura, ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell 153, 575-589 (2013).
123. B. Xhemalce, S. C. Robson, T. Kouzarides, Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell 151, 278-288 (2012).
124. X. Tang, M. Li, L. Tucker, B. Ramratnam, Glycogen synthase kinase 3 beta (GSK3b) phosphorylates the RNAase III enzyme Drosha at S300 and S302. PLOS One 6, e20391 (2011).
125. X. Tang, Y. Zhang, L. Tucker, B. Ramratnam, Phosphorylation of the RNase III enzyme Drosha at Serine300 or Serine302 is required for its nuclear localization. Nucleic Acids Res. 38, 6610-6619 (2010).
126. X.Tang, S. Wen, D.Zheng, L. Tucker, L. Cao, D.Pantazatos, S. F. Moss, B. Ramratnam, Acetylation of Drosha on the N-terminus inhibits its degradation by ubiquitination. PLOS One 8, e72503 (2013).
127. T. Wada, J. Kikuchi, Y. Furukawa, Histone deacetylase 1 enhances microRNA processing via deacetylation of DGCR8. EMBO Rep. 13, 142-149 (2012).
128. K. M. Herbert, G. Pimienta, S. J. DeGregorio, A. Alexandrov, J. A. Steitz, Phosphoryl-ation of DGCR8 increases its intracellular stability and induces a progrowth miRNA profile. Cell Rep. 5, 1070-1081 (2013).
129. Z. Paroo, X. Ye, S. Chen, Q. Liu, Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 139, 112-122 (2009).
130. Y. W. Iwasaki, K. Kiga, H. Kayo, Y. Fukuda-Yuzawa, J. Weise, T. Inada, M. Tomita, Y. Ishihama, T. Fukao, Global microRNA elevation by inducible Exportin 5 regulates cell cycle entry. RNA 19, 490-497 (2013).
131. J. Winter, S. Diederichs, Argonaute proteins regulate microRNA stability: Increased microRNA abundance by Argonaute proteins is due to microRNA stabilization. RNA Biol. 8, 1149-1157 (2011).
132. H. H. Qi, P. P. Ongusaha, J. Myllyharju, D. Cheng, O. Pakkanen, Y. Shi, S. W. Lee, J. Peng, Y. Shi, Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 455, 421-424 (2008).
133. C. Wu, J. So, B. N. Davis-Dusenbery, H. H. Qi, D. B. Bloch, Y. Shi, G. Lagna, A. Hata, Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2. Mol. Cell. Biol. 31, 4760-4774 (2011).
134. Y. Zeng, H. Sankala, X. Zhang, P. R. Graves, Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem. J. 413, 429-436 (2008).
135. S. R.Horman, M.M. Janas, C. Litterst, B.Wang, I.J. MacRae, M.J. Sever, D.V.Morrissey, P. Graves, B. Luo, S. Umesalma, H. H. Qi, L. J. Miraglia, C. D. Novina, A. P. Orth, Aktmediated phosphorylation of argonaute 2 downregulates cleavage and upregulates translational repression of microRNA targets. Mol. Cell 50, 356-367 (2013).
136. J. Shen, W. Xia, Y. B. Khotskaya, L. Huo, K. Nakanishi, S. O. Lim, Y. Du, Y. Wang, W. C. Chang, C. H. Chen, J. L. Hsu, Y. Wu, Y. C. Lam, B. P. James, X. Liu, C. G. Liu, D. J. Patel, M. C. Hung, EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383-387 (2013).
137. Y. Bronevetsky, A. V. Villarino, C. J. Eisley, R. Barbeau, A. J. Barczak, G. A. Heinz, E. Kremmer, V. Heissmeyer, M. T. McManus, D. J. Erle, A. Rao, K. M. Ansel, T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J. Exp. Med. 210, 417-432 (2013).
138. G. J. Seo, R. P. Kincaid, T. Phanaksri, J. M. Burke, J. M. Pare, J. E. Cox, T. Y. Hsiang, R. M. Krug, C. S. Sullivan, Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 14, 435-445 (2013).
139. U. Sahin, P. Lapaquette, A. Andrieux, G. Faure, A. Dejean, Sumoylation of human argonaute 2 at lysine-402 regulates its stability. PLOS One 9, e102957 (2014).
140. G. La Rocca, S. H. Olejniczak, A. J. González, D. Briskin, J. A. Vidigal, L. Spraggon, R. G. DeMatteo, M. R. Radler, T. Lindsten, A. Ventura, T. Tuschl, C. S. Leslie, C. B. Thompson, In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc. Natl. Acad. Sci. U.S.A. 112, 767-772 (2015).